114 related articles for article (PubMed ID: 203417)
1. Long-term therapy with 1alpha-hydroxyvitamin D3 in children with 'pseudo-deficiency' rickets.
Balsan S; Garabedian M; Courtecuisse V; Guéris J; Dommergues JP; Creignou L; le Denuff MJ; Rivron J
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():225s-230s. PubMed ID: 203417
[TBL] [Abstract][Full Text] [Related]
2. 1alpha-hydroxyvitamin D3 in the treatment of nutritional and metabolic rickets and osteomalacia.
Gertner JM; Brenton DB; Edwards RH
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():239s-244s. PubMed ID: 203419
[TBL] [Abstract][Full Text] [Related]
3. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-term treatment with massive doses of 1 alpha-hydroxyvitamin D3 on calcium-phosphate balance in patients with vitamin D-dependent rickets type II.
Takeda E; Yokota I; Saijo T; Kawakami I; Ito M; Kuroda Y
Acta Paediatr Jpn; 1990 Feb; 32(1):39-43. PubMed ID: 2158205
[TBL] [Abstract][Full Text] [Related]
5. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia.
Takeda E; Kuroda Y; Saijo T; Naito E; Kobashi H; Yokota I; Miyao M
Pediatrics; 1987 Jul; 80(1):97-101. PubMed ID: 3037475
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D resistant hypophosphataemic osteomalacia: treatment with 1alpha-hydroxyvitamin D3.
Peacock M; Heyburn PJ; Aaron JE
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():231s-237s. PubMed ID: 203418
[TBL] [Abstract][Full Text] [Related]
7. Treatment of senile osteoporosis with 1alpha-hydroxyvitamin D3.
Sørensen OH; Andersen RB; Christensen MS; Friis T; Hjorth L; Jørgensen FS; Lund B; Melsen F; Mosekilde L
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():169s-175s. PubMed ID: 342143
[TBL] [Abstract][Full Text] [Related]
8. The effect of 1alpha-hydroxyvitamin D3 in pre-dialysis renal bone disease.
Pierides AM; Ellis HA; Simpson W; Cook D; Kerr DN
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():109s-116s. PubMed ID: 606409
[TBL] [Abstract][Full Text] [Related]
9. The management of siblings with familial hypophosphatemic rickets.
Lapatsanis PD; Sbyrakis S; Megreli C; Edelstein S
Helv Paediatr Acta; 1983 Oct; 38(4):373-81. PubMed ID: 6654689
[TBL] [Abstract][Full Text] [Related]
10. 25-Hydroxycholecalciferol. A comparative study in deficiency rickets and different types of resistant rickets.
Balsan S; Garabedian M
J Clin Invest; 1972 Apr; 51(4):749-59. PubMed ID: 4335443
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment of familial hypophosphatemic rickets with oral phosphate and 1 alpha-hydroxyvitamin D3.
Rasmussen H; Pechet M; Anast C; Mazur A; Gertner J; Broadus AE
J Pediatr; 1981 Jul; 99(1):16-25. PubMed ID: 6265614
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood.
Seino Y; Shimotsuji T; Ishii T; Ishida M; Ikehara C; Yamaoka K; Yabuuchi H; Dokoh S
Arch Dis Child; 1980 Jan; 55(1):49-53. PubMed ID: 6246841
[TBL] [Abstract][Full Text] [Related]
13. [Administration of phosphates and 1 alpha-hydroxyvitamin D3 during the postoperative immobilization of children with familial hypophosphatemic rickets].
Pronicka E; Wieczorek E; Kulczycka H; Rowińska E; Tylman D; Pomierna I; Fijałkowski S
Pol Tyg Lek; 1985 Sep; 40(35):992-6. PubMed ID: 4070045
[No Abstract] [Full Text] [Related]
14. [A report on two siblings with vitamin D resistant rickets treated with 1 alpha-hydroxy-vitamin D3 until completion of the growth].
Yoshikawa S; Ohno A; Amagai H; Ikeda K
Nihon Seikeigeka Gakkai Zasshi; 1992 Nov; 66(11):1137-45. PubMed ID: 1336532
[TBL] [Abstract][Full Text] [Related]
15. Rickets with alopecia-remission following a course of 1-alpha-hydroxy vitamin D3 therapy.
Manandhar DS; Sarkawi S; Hunt MC
Eur J Pediatr; 1989 Aug; 148(8):761-3. PubMed ID: 2551693
[TBL] [Abstract][Full Text] [Related]
16. Bone disease in children with chronic renal failure: therapy with 1alpha-hydroxyvitamin D3.
Postlethwaite RJ; Houston IB
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():117s-124s. PubMed ID: 304772
[TBL] [Abstract][Full Text] [Related]
17. Response to crystalline 1alpha-hydroxyvitamin D3 in vitamin D dependency.
Reade TM; Scriver CR; Glorieux FH; Nogrady B; Delvin E; Poirier R; Holick F; DeLuca HF
Pediatr Res; 1975 Jul; 9(7):593-9. PubMed ID: 1161348
[TBL] [Abstract][Full Text] [Related]
18. 24,25 Dihydroxyvitamin D supplementation corrects hyperparathyroidism and improves skeletal abnormalities in X-linked hypophosphatemic rickets--a clinical research center study.
Carpenter TO; Keller M; Schwartz D; Mitnick M; Smith C; Ellison A; Carey D; Comite F; Horst R; Travers R; Glorieux FH; Gundberg CM; Poole AR; Insogna KL
J Clin Endocrinol Metab; 1996 Jun; 81(6):2381-8. PubMed ID: 8964881
[TBL] [Abstract][Full Text] [Related]
19. Effect of 1alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on intestine and bone in glucocorticoid-treated patients.
Lund B; Andersen RB; Friis T; Hjorth L; Jørgensen FS; Norman AW; Sørensen OH
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():177s-181s. PubMed ID: 606415
[TBL] [Abstract][Full Text] [Related]
20. A case of hypophosphataemic vitamin D-resistant rickets treated with initial massive doses of 1 alpha-hydroxy-vitamin D3 alone.
Muraki K; Nishi Y; Tsuda K; Yoshimitsu K; Usui T
Acta Paediatr Scand; 1983 Sep; 72(5):763-8. PubMed ID: 6314737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
